Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025

デジタルパソロジーの世界市場予測(~2025):製品別、種類別、用途別、エンドユーザー別

◆タイトル:Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025
◆商品コード:HIT 2608
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年10月27日
◆ページ数:211
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はデジタルパソロジーの世界市場が2020年553百万ドルから2025年1,054百万ドルまで、年平均13.8%成長すると予想しています。本調査レポートでは、デジタルパソロジーの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(スキャナー、ソフトウェア、通信システム、ストレージシステム)分析、種類別(ヒト病理、獣医病理)分析、用途別(創薬、疾患診断、電話相談、トレーニング・教育)分析、エンドユーザー別(製薬・バイオテクノロジー企業、病院・参照研究所、学術・研究機関)分析、地域別分析、競争状況、企業評価マトリックス・企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・デジタルパソロジーの世界市場規模:製品別(スキャナー、ソフトウェア、通信システム、ストレージシステム)
・デジタルパソロジーの世界市場規模:種類別(ヒト病理、獣医病理)
・デジタルパソロジーの世界市場規模:用途別(創薬、疾患診断、電話相談、トレーニング・教育)
・デジタルパソロジーの世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、病院・参照研究所、学術・研究機関)
・デジタルパソロジーの世界市場規模:地域別
・競争状況
・企業評価マトリックス・企業情報

“The global digital pathology market is projected to reach USD 1,054 million by 2025 from USD 553 million in 2020, at a CAGR of 13.8% during the forecast period.”
The key factors driving the growth of this market include the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent.

“Adoption of artificial intelligence is expected to increase during the forecast period.”
The adoption of AI in healthcare has been rising in recent years due to its ability to optimize clinical processes, thereby solving a variety of problems in the healthcare industry. AI helps patients receive correct diagnosis in a timely manner, maximize hospital efficiency, and reduce the waiting time for patients, thereby enhancing overall healthcare. AI helps in collecting, storing, and normalizing data along with tracing its lineage.

“The software segment will grow at the highest rate during the forecast period.”
On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the digital pathology market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe, and the high cost of scanners. On the other hand, the software segment is projected to witness the highest growth rate during the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.

“By type, the human pathology segment accounted for the largest share of the digital pathology market in 2019.”
On the basis of type, the global digital pathology market is segmented into human and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2019. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.

“The market in North America is projected to witness the highest growth rate during the forecast period (2020–2025).”
North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of cancer and increasing initiatives by industry players. On the other hand, the Asia Pacific region is expected to grow at the second-highest CAGR during the forecast period. Factors such as a large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
• By Category (Demand-side): Pharmaceutical & Biotechnology Companies: 55%, Hospitals and Reference Laboratories: 35%, and Academic & Research Institutes: 10%
• By Designation: C-level: 35%, Director-level: 25%, and Managers: 40%
• By Region: North America: 35%, Europe: 32%, Asia: 22%, and the RoW: 11%

Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan) are the leading players in the global digital pathology market. Other notable players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Research Coverage:
The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the product, type, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market.

【レポートの目次】

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 21
1.2.1 INCLUSIONS AND EXCLUSIONS 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
1.7 SUMMARY OF CHANGES 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
FIGURE 1 RESEARCH DESIGN 25
2.1.1 SECONDARY DATA 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY DATA 26
FIGURE 2 PRIMARY SOURCES 26
2.1.2.1 Key data from primary sources 27
2.1.2.2 Breakdown of primary sources 28
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION,
AND REGION 28
2.2 MARKET SIZE ESTIMATION 28
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 29
FIGURE 5 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION) 29
FIGURE 6 SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2019) 30
FIGURE 7 BOTTOM-UP APPROACH 31
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 32
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2020-2025) 32
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 34
FIGURE 10 DATA TRIANGULATION METHODOLOGY 34
2.4 MARKET SHARE ESTIMATION 35
2.5 ASSUMPTIONS FOR THE STUDY 35
2.6 COVID-19 HEALTH ASSESSMENT 36

2.7 COVID-19 ECONOMIC ASSESSMENT 36
2.7.1 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 36
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE DIGITAL PATHOLOGY MARKET 39
3 EXECUTIVE SUMMARY 40
FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 40
FIGURE 14 DIGITAL PATHOLOGY MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 41
FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 41
FIGURE 16 DIGITAL PATHOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 42
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET 43
4 PREMIUM INSIGHTS 44
4.1 DIGITAL PATHOLOGY MARKET OVERVIEW 44
FIGURE 18 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 44
4.2 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT AND COUNTRY (2019) 45
FIGURE 19 SCANNERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019 45
4.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 20 UK AND CHINA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET DURING THE FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS 47
5.2.1 DRIVERS 47
5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency 47
5.2.1.2 Rising prevalence of cancer 48
TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 48
5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics 49
5.2.1.4 Increasing initiatives by industry players 50
5.2.2 RESTRAINTS 50
5.2.2.1 High cost of digital pathology systems 50
5.2.3 OPPORTUNITIES 50
5.2.3.1 Introduction of affordable scanners for private pathology practices 50
5.2.3.2 Increasing demand for personalized medicine 51
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008–2016 51
5.2.3.3 High growth opportunities in emerging economies 52
5.2.4 CHALLENGES 52
5.2.4.1 Lack of trained pathologists 52
TABLE 4 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018 52
5.3 COVID-19 IMPACT ANALYSIS 53
5.3.1 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET 53
FIGURE 21 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET 53
5.4 ECOSYSTEM MARKET MAP 54
FIGURE 22 DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP 54
5.5 TRENDS IN AVERAGE SELLING PRICE 55
FIGURE 23 DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS 55
5.6 IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS 55
FIGURE 24 TIMELINE AND TRANSITION TO NEW MDR AND IVDR 56
5.6.1 IMPACT ON CLINICAL LAB SERVICES 57
5.6.2 IMPACT ON IVD 58
5.6.3 IMPACT ON DIGITAL PATHOLOGY 58
5.7 TECHNOLOGY ANALYSIS 58
5.7.1 AI IN DIGITAL PATHOLOGY 59
TABLE 5 DIGITAL PATHOLOGY AI MARKET, BY REGION, 2018–2025 (USD MILLION) 59
5.8 PATENT ANALYSIS 60
5.8.1 METHODOLOGY 60
5.8.2 PUBLICATION TRENDS 60
FIGURE 25 PUBLICATION TRENDS, 2015–2020 60
5.8.3 JURISDICTION ANALYSIS 60
FIGURE 26 JURISDICTION ANALYSIS, 2015–2020 61
5.8.4 TOP APPLICANTS 61
FIGURE 27 TOP APPLICANTS, 2015–2020 61
6 DIGITAL PATHOLOGY MARKET, BY PRODUCT 62
6.1 INTRODUCTION 63
TABLE 6 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 63
6.2 SCANNERS 63
6.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2019 63
TABLE 7 SCANNING MAGNIFICATION AND APPLICATIONS 64
TABLE 8 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS 64
TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 65
TABLE 10 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION,
2018–2025 (USD MILLION) 65
TABLE 11 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018–2025 (UNITS) 66
TABLE 12 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 66
6.2.2 BRIGHTFIELD SCANNERS 66
TABLE 13 DIGITAL PATHOLOGY BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS 66
TABLE 14 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 67
6.2.3 FLUORESCENCE SCANNERS 67
TABLE 15 DIGITAL PATHOLOGY FLUORESCENCE SCANNERS OFFERED
BY KEY MARKET PLAYERS 67
TABLE 16 FLUORESCENCE SCANNERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 68
6.2.4 OTHER DIGITAL PATHOLOGY SCANNERS 69
TABLE 17 OTHER DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 69
6.3 SOFTWARE 70
6.3.1 DIGITAL PATHOLOGY SOFTWARE OFFERS ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES 70
TABLE 18 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS 70
TABLE 19 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 71
TABLE 20 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 71
6.3.2 INFORMATION MANAGEMENT SOFTWARE 72
TABLE 21 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 72
6.3.3 IMAGE ANALYSIS SOFTWARE 73
TABLE 22 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 73
6.3.4 VISUALIZATION SOFTWARE 74
TABLE 23 VISUALIZATION SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
6.4 COMMUNICATION SYSTEMS 75
6.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH 75
TABLE 24 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY 75
TABLE 25 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS OFFERED BY KEY MARKET PLAYERS 76
TABLE 26 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
6.5 STORAGE SYSTEMS 77
6.5.1 NEED FOR STORING HIGH-QUALITY IMAGES IN A SAFE AND RELIABLE FORM TO DRIVE MARKET GROWTH 77
TABLE 27 DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS 78
TABLE 28 DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 78
7 DIGITAL PATHOLOGY MARKET, BY TYPE 79
7.1 INTRODUCTION 80
TABLE 29 DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 80
7.2 HUMAN PATHOLOGY 80
7.2.1 HUMAN PATHOLOGY SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 80
TABLE 30 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 81
7.3 VETERINARY PATHOLOGY 81
7.3.1 VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS—A KEY FACTOR DRIVING MARKET GROWTH 81
TABLE 31 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 82
8 DIGITAL PATHOLOGY MARKET, BY APPLICATION 83
8.1 INTRODUCTION 84
TABLE 32 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 84
8.2 DRUG DISCOVERY 84
8.2.1 INCREASING R&D SPENDING WILL PROVIDE IMPETUS TO MARKET GROWTH 84
TABLE 33 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH 84
TABLE 34 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY,
2018–2025 (USD MILLION) 85
8.3 DISEASE DIAGNOSIS 86
8.3.1 DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD 86
TABLE 35 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2018–2025 (USD MILLION) 87
8.4 TELECONSULTATION 87
8.4.1 THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD 87
TABLE 36 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY,
2018–2025 (USD MILLION) 88
8.5 TRAINING & EDUCATION 89
8.5.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION AND TRAINING PROVIDED TO PATHOLOGISTS 89
TABLE 37 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2018–2025 (USD MILLION) 89
9 DIGITAL PATHOLOGY MARKET, BY END USER 90
9.1 INTRODUCTION 91
TABLE 38 DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION) 91
TABLE 39 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2018–2025 (USD MILLION) 91
TABLE 40 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2018–2025 (UNITS) 92
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 92
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET 92
TABLE 41 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 42 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 93
TABLE 43 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (UNITS) 94
9.3 HOSPITALS & REFERENCE LABORATORIES 94
9.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 94
TABLE 44 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS 95
TABLE 45 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 46 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (USD MILLION) 96
TABLE 47 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (UNITS) 97
9.4 ACADEMIC & RESEARCH INSTITUTES 97
9.4.1 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD 97
TABLE 48 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2018–2025 (USD MILLION) 98
TABLE 49 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 99
TABLE 50 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (UNITS) 99
10 DIGITAL PATHOLOGY MARKET, BY REGION 100
10.1 INTRODUCTION 101
FIGURE 28 DIGITAL PATHOLOGY MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 101
TABLE 51 DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 101
10.2 NORTH AMERICA 102
FIGURE 29 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT 102
TABLE 52 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 103
TABLE 53 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 103
TABLE 54 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 103
TABLE 55 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 104
TABLE 56 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 104
TABLE 57 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 104
TABLE 58 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 105
TABLE 59 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION) 105
TABLE 60 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS) 105

10.2.1 US 106
10.2.1.1 Favorable reimbursement scenario for digital pathology in the US 106
TABLE 61 US: CANCER CASES, 2018 106
TABLE 62 CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US 107
TABLE 63 US: KEY MACROINDICATORS 107
TABLE 64 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 108
TABLE 65 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 108
TABLE 66 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 108
TABLE 67 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 68 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 109
TABLE 69 US: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 109
10.2.2 CANADA 110
10.2.2.1 Growing need for high-quality cancer diagnosis and government initiatives to drive the market growth in Canada 110
TABLE 70 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING 111
TABLE 71 CANADA: KEY MACROINDICATORS 111
TABLE 72 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 112
TABLE 73 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 74 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 75 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
TABLE 76 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 113
TABLE 77 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025(USD MILLION) 113
10.3 EUROPE 114
FIGURE 30 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT 114
TABLE 78 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 115
TABLE 79 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 115
TABLE 80 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 81 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 82 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 83 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 116
TABLE 84 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 117
TABLE 85 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2018–2025 (USD MILLION) 117
TABLE 86 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2018–2025 (UNITS) 117
10.3.1 UK 118
10.3.1.1 The UK is the largest market for digital pathology in Europe 118
TABLE 87 CONFERENCES/COURSES HELD/TO BE HELD IN THE UK 119
TABLE 88 UK: KEY MACROINDICATORS 119
TABLE 89 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 120
TABLE 90 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 91 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 92 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 93 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 121
TABLE 94 UK: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 121
10.3.2 GERMANY 122
10.3.2.1 High healthcare expenditure and supportive health insurance to drive market growth in Germany 122
TABLE 95 GERMANY: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 122
TABLE 96 GERMANY: KEY MACROINDICATORS 123
TABLE 97 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 123
TABLE 98 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 99 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 100 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION)S 124
TABLE 101 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 124
TABLE 102 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 125
10.3.3 SWEDEN 125
10.3.3.1 Increasing government initiatives and deployment of digital pathology solutions 125
TABLE 103 SWEDEN: CANCER CASES, 2018 125
TABLE 104 SWEDEN: KEY MACROINDICATORS 126
TABLE 105 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025(USD MILLION) 126
TABLE 106 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
TABLE 107 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
TABLE 108 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
TABLE 109 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 128
TABLE 110 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 128
10.3.4 DENMARK 128
10.3.4.1 High cancer prevalence to drive the market growth in Denmark 128
FIGURE 31 DENMARK: CANCER PREVALENCE, 2012–2020 129
TABLE 111 DENMARK: KEY MACROINDICATORS 129
TABLE 112 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 130
TABLE 113 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 114 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 115 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 116 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 131
TABLE 117 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 131
10.3.5 FRANCE 132
10.3.5.1 Increasing incidence of cancer to drive the market growth during the forecast period 132
TABLE 118 FRANCE: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 132
TABLE 119 FRANCE: KEY MACROINDICATORS 132
TABLE 120 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 133
TABLE 121 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 122 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 123 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 124 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 134
TABLE 125 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 134
10.3.6 REST OF EUROPE (ROE) 135
TABLE 126 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 135
TABLE 127 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 135
TABLE 128 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 129 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 130 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 136
TABLE 131 ROE: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 137
10.4 ASIA PACIFIC 137
TABLE 132 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 137
TABLE 133 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 138
TABLE 134 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 138
TABLE 135 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 138
TABLE 136 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 137 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 139
TABLE 138 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 139
TABLE 139 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION) 140
TABLE 140 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS) 140
10.4.1 CHINA 140
10.4.1.1 Favorable initiatives for the adoption of telepathology in China 140
TABLE 141 CHINA: CANCER CASES, 2018 141
TABLE 142 CHINA: KEY MACROINDICATORS 141
TABLE 143 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 142
TABLE 144 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 145 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 146 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 147 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 143
TABLE 148 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 143
10.4.2 JAPAN 144
10.4.2.1 Increasing initiatives by industry players for cancer diagnosis to drive market growth 144
TABLE 149 JAPAN: KEY MACROINDICATORS 144
TABLE 150 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 144
TABLE 151 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 152 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 153 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 145
TABLE 154 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 146
TABLE 155 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 146
10.4.3 INDIA 146
10.4.3.1 Growing number of cancer cases in India to drive the market growth 146
TABLE 156 INDIA: KEY MACROINDICATORS 147
TABLE 157 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 147
TABLE 158 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 148
TABLE 159 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 148
TABLE 160 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 161 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 149
TABLE 162 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 149
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 149
TABLE 163 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 150
TABLE 164 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 165 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 166 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 167 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 151
TABLE 168 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 151
10.5 REST OF THE WORLD 152
TABLE 169 ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 152
TABLE 170 ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 152
TABLE 171 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 152
TABLE 172 ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
TABLE 173 ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 174 ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 153
TABLE 175 ROW: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 154
TABLE 176 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2018–2025 (USD MILLION) 154
TABLE 177 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2018–2025 (UNITS) 154
10.5.1 LATIN AMERICA 155
10.5.1.1 Increasing purchasing power and healthcare affordability to drive the market growth in Latin America 155
TABLE 178 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 155
TABLE 179 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 180 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 181 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 182 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 156
TABLE 183 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 157
10.5.2 MIDDLE EAST & AFRICA 157
10.5.2.1 Infrastructural developments in the region to support market growth 157
TABLE 184 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 158
TABLE 185 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 186 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 187 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2018–2025 (USD MILLION) 159
TABLE 188 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 159
TABLE 189 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 159
11 COMPETITIVE LANDSCAPE 160
11.1 INTRODUCTION 160
11.2 MARKET EVALUATION FRAMEWORK 160
FIGURE 32 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES 160
11.3 MARKET SHARE ANALYSIS 161
FIGURE 33 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 161
11.4 DIGITAL PATHOLOGY MARKET: GEOGRAPHICAL ASSESSMENT 162
FIGURE 34 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019) 162
11.5 DIGITAL PATHOLOGY MARKET: R&D EXPENDITURE 162
FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019) 162
11.6 COMPETITIVE SCENARIO 163
11.6.1 KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET 163
TABLE 190 PARTNERSHIPS & COLLABORATIONS (JANUARY 2017–SEPTEMBER 2020) 163
11.6.2 KEY PRODUCT LAUNCHES 163
TABLE 191 PRODUCT LAUNCHES (JANUARY 2017–SEPTEMBER 2020) 163
11.6.3 KEY EXPANSIONS 164
TABLE 192 EXPANSIONS (JANUARY 2017–SEPTEMBER 2020) 164
12 COMPANY EVALUATION MATRIX & COMPANY PROFILES 165
12.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY 165
12.2 COMPANY EVALUATION MATRIX 165
12.2.1 STARS 165
12.2.2 EMERGING LEADERS 165
12.2.3 PERVASIVE 165
12.2.4 PARTICIPANTS 166
FIGURE 36 DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 166
12.3 COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SMES 167
12.3.1 PROGRESSIVE COMPANIES 167
12.3.2 STARTING BLOCKS 167
12.3.3 RESPONSIVE COMPANIES 167
12.3.4 DYNAMIC COMPANIES 167
FIGURE 37 COMPETITIVE LEADERSHIP MAPPING OF THE DIGITAL PATHOLOGY MARKET: STARTUPS/SMES 168
12.4 COMPANY PROFILES 169
(Business overview, Products offered, Recent developments & MnM View)*
12.4.1 LEICA BIOSYSTEMS 169
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 169
12.4.2 KONINKLIJKE PHILIPS 173
FIGURE 39 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019) 173
12.4.3 HAMAMATSU PHOTONICS 176
FIGURE 40 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019) 176
12.4.4 F. HOFFMANN-LA ROCHE LTD. 178
FIGURE 41 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019) 178
12.4.5 SECTRA AB 181
FIGURE 42 SECTRA AB: COMPANY SNAPSHOT (2019) 181
12.4.6 3DHISTECH 184
12.4.7 APOLLO ENTERPRISE IMAGING CORP. 186
12.4.8 XIFIN, INC. 187
12.4.9 HURON DIGITAL PATHOLOGY 188
12.4.10 VISIOPHARM 190
12.4.11 CORISTA 192
12.4.12 INDICA LABS 193
12.4.13 OBJECTIVE PATHOLOGY SERVICES 194

12.4.14 OPTRASCAN, INC. 195
12.4.15 GLENCOE SOFTWARE, INC. 197
12.4.16 PAIGE 198
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.5 OTHER COMPANIES 199
12.5.1 PATHAI 199
12.5.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD. 199
12.5.3 INSPIRATA, INC. 200
12.5.4 MIKROSCAN TECHNOLOGIES, INC. 200
12.5.5 PROSCIA, INC. 200
12.5.6 KANTERON SYSTEMS 201
13 APPENDIX 202
13.1 DISCUSSION GUIDE 202
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 207
13.3 AVAILABLE CUSTOMIZATIONS 209
13.4 RELATED REPORTS 209
13.5 AUTHOR DETAILS 210



★調査レポート[デジタルパソロジーの世界市場予測(~2025):製品別、種類別、用途別、エンドユーザー別] ( Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025 / HIT 2608) 販売に関する免責事項
[デジタルパソロジーの世界市場予測(~2025):製品別、種類別、用途別、エンドユーザー別] ( Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025 / HIT 2608) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆